000 | 02009 a2200565 4500 | ||
---|---|---|---|
005 | 20250513124943.0 | ||
264 | 0 | _c19971020 | |
008 | 199710s 0 0 eng d | ||
022 | _a0923-7534 | ||
024 | 7 |
_a10.1023/a:1008270131789 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBajetta, E | |
245 | 0 | 0 |
_aA multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: endocrine and clinical results. The Italian Trials in Medical Oncology (I.T.M.O.) group. _h[electronic resource] |
260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cJul 1997 |
||
300 |
_a649-54 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAndrostenedione _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 | _aAromatase Inhibitors |
650 | 0 | 4 |
_aBreast Neoplasms _xblood |
650 | 0 | 4 |
_aEstradiol _xblood |
650 | 0 | 4 |
_aEstrone _xblood |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections, Intramuscular |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPostmenopause |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aZilembo, N | |
700 | 1 | _aBarni, S | |
700 | 1 | _aNoberasco, C | |
700 | 1 | _aMartinetti, A | |
700 | 1 | _aFerrari, L | |
700 | 1 | _aSchieppati, G | |
700 | 1 | _aBuzzoni, R | |
700 | 1 | _aJirillo, A | |
700 | 1 | _aAmichetti, M | |
700 | 1 | _aD'Aprile, M | |
700 | 1 | _aComella, G | |
700 | 1 | _aBichisao, E | |
700 | 1 | _aBolelli, G F | |
700 | 1 | _aAttili, A | |
700 | 1 | _aBombardieri, E | |
773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 8 _gno. 7 _gp. 649-54 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1023/a:1008270131789 _zAvailable from publisher's website |
999 |
_c9274797 _d9274797 |